{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T20:22:33Z","timestamp":1761164553835,"version":"build-2065373602"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","jopan.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of PeriAnesthesia Nursing"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.jopan.2021.05.009","type":"journal-article","created":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T11:50:21Z","timestamp":1637322621000},"page":"11-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Botulinum Toxin A Injection and Perianesthesia Neuromuscular Monitoring: Case Report and Review"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4593-5550","authenticated-orcid":false,"given":"Carol","family":"Munsterman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1026-8927","authenticated-orcid":false,"given":"Theresa","family":"Broussard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4679-972X","authenticated-orcid":false,"given":"Penelope","family":"Strauss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jopan.2021.05.009_bib0001","unstructured":"Plastic Surgery Statistics Report. (2019). Available at https:\/\/www.plasticsurgery.org\/documents\/News\/Statistics\/2019\/plastic-surgery-statistics-full-report-2019.pdf. Accessed March 14, 2021."},{"key":"10.1016\/j.jopan.2021.05.009_bib0002","first-page":"97","article-title":"Updates on the cosmetic and therapeutic use of botulinum toxin","volume":"11","author":"Vasconcellos","year":"2019","journal-title":"Surg Cosmetic Dermatol"},{"key":"10.1016\/j.jopan.2021.05.009_bib0003","first-page":"112","article-title":"Treatment of chronic pain associated with nocturnal bruxism with botulinum toxin. A prospective and randomized clinical study","volume":"18","author":"Al-Wayli","year":"2017","journal-title":"J Clin Exp Dentistry"},{"key":"10.1016\/j.jopan.2021.05.009_bib0004","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/1534734618816589","article-title":"Botulinum Toxin A injection for treatment of chronic skin ulcer: a case series and literature review","volume":"18","author":"Zhong","year":"2019","journal-title":"Int J Lower Extremity Wounds"},{"key":"10.1016\/j.jopan.2021.05.009_bib0005","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3390\/toxins10040164","article-title":"Lumbar Sympathetic block with botulinum Toxin Type A and Type B for complex regional pain syndrome","volume":"10","author":"Lee","year":"2018","journal-title":"Toxins"},{"key":"10.1016\/j.jopan.2021.05.009_bib0006","article-title":"Paralysis of the orbicularis muscle of the eye using botulinum toxin type A in the treatment for dry eye","volume":"95","author":"Serna-Ojeda","year":"2016","journal-title":"Acta Ophthalmologica"},{"key":"10.1016\/j.jopan.2021.05.009_bib0007","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-027953","article-title":"Cochrane systematic review and meta-analysis of botulinum toxin for the prevention of migraine","volume":"9","author":"Herd","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.jopan.2021.05.009_bib0008","article-title":"Subcutaneous botulinum toxin-A injection for treating postherpetic neuralgia","volume":"33","author":"Hu","year":"2019","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jopan.2021.05.009_bib0009","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.00513","article-title":"Efficacy of botulinum toxin for treating sialorrhea in neuromuscular conditions","volume":"11","author":"Singh","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.jopan.2021.05.009_bib0010","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001408.pub2","article-title":"Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy","author":"Blumetti","year":"2019","journal-title":"Cochr Database System Rev"},{"key":"10.1016\/j.jopan.2021.05.009_bib0011","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s13555-020-00414-7","article-title":"Intradermal micro-dosing of abobotulinumtoxina for face-lifting: how long does it last?","volume":"10","author":"Wanitphakdeedecha","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jopan.2021.05.009_bib0012","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/14764170701883660","article-title":"The five D's of botulinum toxin: doses, dilution, diffusion, duration and dogma","volume":"10","author":"Paula de Sa Earp","year":"2008","journal-title":"J Cosmetic Laser Ther"},{"key":"10.1016\/j.jopan.2021.05.009_bib0013","first-page":"e20","article-title":"Assessment of neuromuscular function in patients with prior cosmetic procedures: a case report","volume":"19","author":"Le","year":"2019","journal-title":"Eplasty"},{"key":"10.1016\/j.jopan.2021.05.009_bib0014","doi-asserted-by":"crossref","DOI":"10.1111\/anae.13482","article-title":"Botox injections and monitoring neuromuscular blockade - a reminder","volume":"71","author":"Cross","year":"2016","journal-title":"Anaesthesia"},{"key":"10.1016\/j.jopan.2021.05.009_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21466\/ac.TIOBTAB.2014","article-title":"The implications of Botulinum toxin A (Botox) injections and neuromuscular monitoring","volume":"2","author":"Saxena","year":"2014","journal-title":"Anaesthesia Cases"},{"key":"10.1016\/j.jopan.2021.05.009_bib0016","first-page":"730","article-title":"Assessing neuromuscular function in patients who have received Botox injections","volume":"40","author":"Dunne","year":"2012","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.jopan.2021.05.009_bib0017","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1399-6576.2007.01279.x","article-title":"Anesthetic implications of botulinum toxin type A (Botox) injections for the treatment of the aging face in the parturient","volume":"51","author":"Kuczkowski","year":"2007","journal-title":"Acta Anaesthesiologica Scandinavica"},{"key":"10.1016\/j.jopan.2021.05.009_bib0018","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1097\/00000542-200610000-00049","article-title":"Monitoring complicated by the unknown preoperative cosmetic use of botulinum toxin","volume":"105","author":"Miller","year":"2006","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jopan.2021.05.009_bib0019","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2044.2006.04701.x","article-title":"Botox injections and monitoring neuromuscular blockade","volume":"61","author":"Ward","year":"2006","journal-title":"Anaesthesia"},{"key":"10.1016\/j.jopan.2021.05.009_bib0020","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/anae.13738","article-title":"Conceptual and technical insights into the basis of neuromuscular monitoring","volume":"72","author":"Naguib","year":"2017","journal-title":"Anaesthesia"},{"key":"10.1016\/j.jopan.2021.05.009_bib0021","series-title":"Miller's Anesthesia","first-page":"792","article-title":"Pharmacology of neuromuscular blocking drugs","author":"Gropper","year":"2020"},{"key":"10.1016\/j.jopan.2021.05.009_bib0022","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.toxicon.2017.10.008","article-title":"The travel diaries of tetanus and botulinum neurotoxins","volume":"147","author":"Surana","year":"2018","journal-title":"Toxicon"},{"key":"10.1016\/j.jopan.2021.05.009_bib0023","doi-asserted-by":"crossref","first-page":"853","DOI":"10.5114\/ada.2019.82795","article-title":"The whole truth about botulinum toxin \u2013 a review","volume":"37","author":"Witmanowski","year":"2020","journal-title":"Adv Dermatol Allergol"},{"key":"10.1016\/j.jopan.2021.05.009_bib0024","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1124\/pr.116.012658","article-title":"Botulinum neurotoxins: biology, pharmacology, and toxicology","volume":"69","author":"Pirazzini","year":"2017","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jopan.2021.05.009_bib0025","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.rehab.2015.06.002","article-title":"Muscle structure and stiffness assessment after botulinum toxin type A injection. A systematic review","volume":"58","author":"Mathevon","year":"2015","journal-title":"Ann Phys Rehabilitation Med"},{"key":"10.1016\/j.jopan.2021.05.009_bib0026","first-page":"173","article-title":"The botulinum toxin as a therapeutic agent: molecular and pharmacological insights","author":"Singh","year":"2015","journal-title":"Res Rep Biochem"},{"key":"10.1016\/j.jopan.2021.05.009_bib0027","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.2174\/138161209789271843","article-title":"Current clinical applications of botulinum toxin","volume":"15","author":"Truong","year":"2009","journal-title":"Curr Pharm Design"},{"key":"10.1016\/j.jopan.2021.05.009_bib0028","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.toxicon.2013.02.014","article-title":"The life history of a botulinum toxin molecule","volume":"68","author":"Simpson","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.jopan.2021.05.009_bib0029","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3390\/toxins11090491","article-title":"Immunogenicity associated with botulinum toxin treatment","volume":"11","author":"Bellows","year":"2019","journal-title":"Toxins"},{"key":"10.1016\/j.jopan.2021.05.009_bib0030","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/jocd.13266","article-title":"Complications of botulinum toxin and fillers: a narrative review","volume":"19","author":"Kassir","year":"2019","journal-title":"J Cosmetic Dermatol"},{"key":"10.1016\/j.jopan.2021.05.009_bib0031","doi-asserted-by":"crossref","DOI":"10.1097\/01.ORN.0000472830.12304.2a","article-title":"Identifying and treating postanesthesia emergencies","volume":"9","author":"Strauss","year":"2015","journal-title":"OR Nurse"},{"key":"10.1016\/j.jopan.2021.05.009_bib0032","series-title":"Miller's Anesthesia","first-page":"1354","article-title":"Neuromuscular monitoring","author":"Claudius","year":"2020"},{"key":"10.1016\/j.jopan.2021.05.009_bib0033","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1213\/ane.0b013e31816d1268","article-title":"Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit","volume":"107","author":"Murphy","year":"2008","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jopan.2021.05.009_bib0034","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/ALN.0b013e31826f8fdd","article-title":"Intraoperative neuromuscular monitoring site and residual paralysis","volume":"117","author":"Thilen","year":"2012","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jopan.2021.05.009_bib0035","first-page":"55","article-title":"Neuromuscular monitoring: an update","volume":"25","author":"Dutu","year":"2018","journal-title":"Romanian J Anaesthesia Intensive Care"},{"key":"10.1016\/j.jopan.2021.05.009_bib0036","first-page":"68","article-title":"Presentation of the APSF Collaborative Panel on Neuromuscular Blockade and Patient Safety at the 2017 ASA Annual Meeting","volume":"32","author":"Murphy","year":"2018","journal-title":"APSF Newslett"},{"key":"10.1016\/j.jopan.2021.05.009_bib0037","article-title":"Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults","volume":"8","author":"Hristovska","year":"2017","journal-title":"Cochrane Database System Rev"},{"key":"10.1016\/j.jopan.2021.05.009_bib0038","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1213\/ANE.0b013e3182999672","article-title":"Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block","volume":"117","author":"Kotake","year":"2013","journal-title":"Anesthesia Analgesia"},{"key":"10.1016\/j.jopan.2021.05.009_bib0039","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12871-019-0817-4","article-title":"Usefulness of intra-operative neuromuscular blockade monitoring and reversal agents for postoperative residual neuromuscular blockade: a retrospective observational study","volume":"19","author":"Domenech","year":"2019","journal-title":"BMC Anesthesiol"},{"year":"2021","series-title":"Bloxiverz (neostigmine methylsulfate injection, USP) package insert","key":"10.1016\/j.jopan.2021.05.009_bib0040"},{"key":"10.1016\/j.jopan.2021.05.009_bib0041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/848051","article-title":"Prediction of optimal reversal dose of sugammadex after rocuronium administration in adult surgical patients","volume":"2014","author":"Otomo","year":"2014","journal-title":"Anesthesiol Res Pract"},{"key":"10.1016\/j.jopan.2021.05.009_bib0042","first-page":"19","article-title":"Assessment of neuromuscular function in patients with prior cosmetic procedures: a case report","author":"Le","year":"2019","journal-title":"Eplasty"},{"key":"10.1016\/j.jopan.2021.05.009_bib0043","doi-asserted-by":"crossref","DOI":"10.1186\/s12871-018-0605-6","article-title":"Is lower-dose sugammadex a cost-saving strategy for reversal of deep neuromuscular block? Facts and fiction","volume":"18","author":"de Boer","year":"2018","journal-title":"BMC Anesthesiol"},{"year":"2021","series-title":"Bridion (suggamadex) package insert","key":"10.1016\/j.jopan.2021.05.009_bib0044"},{"key":"10.1016\/j.jopan.2021.05.009_bib0045","doi-asserted-by":"crossref","DOI":"10.1213\/ANE.0000000000005465","article-title":"Unanticipated consequences of switching to sugammadex: anesthesia provider survey on the hormone contraceptive drug interaction","author":"Dwan","year":"2021","journal-title":"Anesthesia Analgesia"},{"key":"10.1016\/j.jopan.2021.05.009_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.jopan.2020.10.007","article-title":"Sugammadex effects on hormonal contraception effectiveness: implementation of uniform postoperative teaching","author":"Hartman","year":"2021","journal-title":"J PeriAnesthesia Nursing"},{"key":"10.1016\/j.jopan.2021.05.009_bib0047","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1034\/j.1399-6576.2002.460912.x","article-title":"Acceleromyography of the orbicularis oculi muscle II: comparing the orbicularis oculi and adductor pollicis muscles","volume":"46","author":"Larsen","year":"2002","journal-title":"Acta Anaesthesiologica Scandinavica"},{"key":"10.1016\/j.jopan.2021.05.009_bib0048","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/0310057X1804600105","article-title":"Anaesthetic issues in robotic-assisted minimally invasive surgery","volume":"46","author":"Pathirana","year":"2018","journal-title":"Anaesthesia Intensive Care"},{"key":"10.1016\/j.jopan.2021.05.009_bib0049","unstructured":"Standards for Nurse Anesthesia Practice. aana.com. http:\/\/www.aana.com\/practice\/practice-manual. Published 2019. Accessed March 25, 2021."}],"container-title":["Journal of PeriAnesthesia Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089947221001301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089947221001301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T18:20:32Z","timestamp":1761070832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089947221001301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1089947221001301"],"URL":"https:\/\/doi.org\/10.1016\/j.jopan.2021.05.009","relation":{},"ISSN":["1089-9472"],"issn-type":[{"type":"print","value":"1089-9472"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Botulinum Toxin A Injection and Perianesthesia Neuromuscular Monitoring: Case Report and Review","name":"articletitle","label":"Article Title"},{"value":"Journal of PeriAnesthesia Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jopan.2021.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Society of PeriAnesthesia Nurses. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}